Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company  | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
| Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
| Glenmark Pharmaceuticals | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $14,000,000 |
| Glenmark Generics Inc. | Glenmark Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
| GLAXOSMITHKLINE, LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
| GlaxoSmithKline Vaccines | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | $172,900 |
| GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
| GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $20,000,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | $317,550 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
| GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2015 | NY-ENV | $24,200 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
| GLAXO SMITH KLINE | GlaxoSmithKline | pharmaceuticals | aviation safety violation | 2014 | FAA | $59,500 |
| Gilead Sciences | Gilead Sciences | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $250,000 |
| GILEAD SCIENCES | Gilead Sciences | pharmaceuticals | workplace safety or health violation | 2000 | OSHA | $5,700 |
| Genzyme Corporation | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
| Geneva Pharmaceuticals | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| General Nutrition Corporation | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2017 | MA-AG | $72,304 |
| GENERAL NUTRITION CORPORATION | Harbin Pharmaceutical Group | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $7,674 |
| General Nutrition Corp. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2002 | FL-AG | $1,000,000 |
| General Nutrition Centers Inc. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2015 | private lawsuit-federal | $350,014 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2005 | private lawsuit-federal | $60,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
| Genentech Inc. | Roche | pharmaceuticals | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| Genentech | Roche | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
| Genentech | Roche | pharmaceuticals | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
| Genentech | Roche | pharmaceuticals | hazardous waste violation | 2023 | EPA | $158,208 |
| GENENTECH | Roche | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $11,240 |
| Genentech | Roche | pharmaceuticals | environmental violation | 2023 | EPA | $158,209 |
| Galena Biopharma, Inc. | SELLAS Life Sciences Group | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
| Fujisawa Healthcare, Inc. | Astellas Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Fort Dodge Animal Health | Zoetis | pharmaceuticals | economic sanction violation | 2004 | OFAC | $26,956 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | USAO | $149,000,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
| Forest Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $790,000 |
| Forest Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
| ExecuPharm, Inc. | Parexel International | pharmaceuticals | Family and Medical Leave Act | 2017 | WHD | $5,900 |
| ETHICON, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $6,518 |
| ETHICON, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $9,832 |
| ETHICON INC | Johnson & Johnson | pharmaceuticals | air pollution violation | 2009 | NJ-ENV | $5,250 |
| ETHICON ENDO SURGERY | Johnson & Johnson | pharmaceuticals | aviation safety violation | 2010 | FAA | $5,500 |
| Ethicon | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2023 | KY-AG | $9,900,000 |
| Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | consumer protection violation | 2019 | CA-AG | $760,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
| Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
| Endo Health Solutions | Endo International | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
| Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
| EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
| EMD Millipore Corporation | Merck KGaA (EMD) | pharmaceuticals | pesticide violation | 2013 | EPA | $2,681,500 |
| EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2021 | OSHA | $10,240 |
| EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | water pollution violation | 2017 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $385,000 |
| EMD Millipore Corp. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2017 | EPA | $385,000 |
| EMD Chemicals, Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2007 | BIS | $44,000 |
| EMD Chemicals, Inc. | Merck KGaA (EMD) | pharmaceuticals | economic sanction violation | 2007 | OFAC | $8,250 |
| EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | pharmaceuticals | motor vehicle safety violation | 2006 | FMCSA | $7,614 |
| EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | pharmaceuticals | motor vehicle safety violation | 2004 | FMCSA | $13,170 |
| EMD Chemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2008 | OH-ENV | $30,700 |
| EMD Chemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2005 | OH-ENV | $32,000 |
| EM INDUSTRIES, INC. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
| ELI LILLY AND COMPANY | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $337,500 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
| ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | pharmaceuticals | air pollution violation | 2009 | EPA | $12,000 |
| Eli Lilly & Co. | Eli Lilly | pharmaceuticals | privacy violation | 2002 | MULTI-AG | $160,000 |
| ELI LILLY & CO LTC | Eli Lilly | pharmaceuticals | air pollution violation | 2019 | IN-ENV | $45,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
